|
|
Volumn 297, Issue 14, 2007, Pages 1535-1536
|
|
Researchers buoyed by novel HIV drugs: Will expand drug arsenal against resistant virus
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CHEMOKINE RECEPTOR CCR5 ANTAGONIST;
INTEGRASE INHIBITOR;
MARAVIROC;
MK 0518;
PROTEINASE INHIBITOR;
RALTEGRAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
4,4 DIFLUORO N ((1S) 3 (EXO 3 (3 ISOPROPYL 5 METHYL 4H 1,2,4 TRIAZOL 4 YL) 8 AZABICYCLO(3.2.1)OCT 8 YL) 1 PHENYLPROPYL)CYCLOHEXANECARBOXAMIDE;
4,4-DIFLUORO-N-((1S)-3-(EXO-3-(3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO(3.2.1)OCT-8-YL)-1-PHENYLPROPYL)CYCLOHEXANECARBOXAMIDE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CYCLOHEXANE DERIVATIVE;
HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR;
NEW DRUG;
ORGANIC COMPOUND;
TRIAZOLE DERIVATIVE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
DOSE RESPONSE;
DRUG MECHANISM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
TREATMENT RESPONSE;
VIRUS STRAIN;
ANTIBIOTIC RESISTANCE;
ARTICLE;
ANTI-HIV AGENTS;
CYCLOHEXANES;
DRUG RESISTANCE, VIRAL;
DRUGS, INVESTIGATIONAL;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HIV INTEGRASE INHIBITORS;
HUMANS;
ORGANIC CHEMICALS;
TRIAZOLES;
|
|
EID: 34247132119
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.297.14.1535 Document Type: Short Survey |
|
Times cited : (21)
|
|
References (0)
|